FFA
ANRO icon

Farther Finance Advisors’s Alto Neuroscience ANRO Stock Holding History

Farther Finance Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290 Hold
11
– – ﹤0.01% 5650
2026
Q1 		$258 Sell
11
-20
-65% -$371 ﹤0.01% 5392
2025
Q4 		$552 Buy
+31
New +$390 ﹤0.01% 5037

Other funds holding ANRO

GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's ANRO Position: Q2 2026 in Review

Farther Finance Advisors held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 11 shares worth $290. The position accounts for ﹤0.01% of the portfolio, ranked #5650.

Farther Finance Advisors first reported a position in ANRO in Q4 2025 and has held it in 3 quarters since. The position peaked at $552 in Q4 2025. 4 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Farther Finance Advisors held 11 shares of Alto Neuroscience worth $290 as of Q2 2026.
  • Farther Finance Advisors left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5650 holding.
  • Farther Finance Advisors first reported a position in Alto Neuroscience in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Alto Neuroscience position peaked at $552 in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.